Dipna Pharmachem Ltd — Quarterly Results & Earnings

₹8.02

-2.59%

Profit Growth YoY314.71%Latest quarter

Sales Growth YoY-18.85%Latest quarter

Sales CAGR 5Y32.54%5 year compound

Profit CAGR 5Y74.47%5 year compound

📋

Quarterly Performance

YoY Profit Growth+314.71%

🔥 Exceptional growth

YoY Sales Growth-18.85%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

2.46%

EPS Growth 5Y

-41.72%

Interest Coverage

Higher = safer debt servicing

2.43

ROE

2.55%

ROCE

6.64%

💡

Growth Analysis

Dipna Pharmachem Ltd reported YoY profit growth of 314.71% and revenue growth of -18.85% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 32.54% and profits at 74.47% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Dipna Pharmachem Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.